Skip navigation

6th Annual Alzheimer’s Drug Development Summit

An Industry Forum on Clinical Advancements for Preventative and Translational Medicine

December 11-12, 2012
  • Philadelphia, Pennsylvania

Available for $298.00

The release of recent, high profile clinical trial results and the turn of AD research to preventative and translational treatments are important updates towards the goal to cure Alzheimer’s disease. These approaches, along with the increasing use of biomarkers are the driving force of new research and development of preventing and treating AD.

As an industry, it is crucial to understand past, current and future research findings and clinical trials to continuing advancing knowledge and innovation to achieve the end goal.

Join us in December to hear critical insights, research and key updates from industry leaders regarding topics such as:

  • Future perspectives from the Dominantly Inherited Alzheimer Network (DIAN)
  • Development, qualification, regulatory approval and standardization of biomarkers
  • Industry-wide effects of notable Alzheimer’s clinical trial implications

For more information about this event or to submit an abstract, please contact Kelly Rose at kelly.rose@cbinet.com or 339.298.2121.